Skip to main content

Table 1 Clinical and epidemiological data obtained for the 36 patients of collective A and B

From: Hospital outbreak caused by linezolid resistant Enterococcus faecium in Upper Austria

Characteristics   
Age, years, median (range) 57 (22–91)  
Sex, n (%)
 Male 23 63.9
 Female 13 36.1
Patient status, n (%)
 Inpatient 35 97.2
 Outpatient 1 2.8
Transfer from other Hospital/LTCF, n (%)
 Yes 8 22.2
 No 25 69.4
 Unknown 3 8.3
LZD therapy (previous 28 days), n (%)
 Yes 10 27.8
 No 25 69.4
 Unknown 1 2.8
Duration of LZD therapy, days, median (range) 9 (3–35)  
LREfm status, n (%)
 Infection 4 11.1
 Colonization 30 83.3
 Unknown 2 5.6
Duration of colonization, days, median (range) 22 (3–245)  
Current antibiotic therapy, n (%)
 Yes 36 100.0
 No 0 0.0
Hospital contact in previous year, n (%)
 Yes 31 86.1
 No 2 5.6
 Unknown 3 8.3
Underlying disease, n (%)
 Hematology-Oncology 25 69.4
 allogeneic SCT 17  
 autologous SCT 3  
 Trauma/orthopedic 4 11.1
 Abdominal surgery/Pancreatitis 4 11.1
 Other 3 8.3
Immunocompromised, n (%)
 Yes 31 86.1
 No 4 11.1
 Unknown 1 2.8
Died during follow-up (until end of 2017), n (%)
 Yes 15 41.7
 No 14 38.9
 Unknown 7 19.4
Source material first LREfm isolate, n (%)
 Stool 18 50.0
 Urine 9 25.0
 Swab (wound, throat, eye) 7 19.4
 Blood culture 1 2.8
 Catheter tip 1 2.8
Source material secondary isolates, n (%)
 Stool 6  
 Blood culture 2  
 Urine 1  
Screening sample, n (%)
 Yes 24 66.6
 No 11 30.5
 Unknown 1 2.77